Author:
Rehman Latif Ur,Afzal Khan Amir,Afridi Pashmina,Ur Rehman Sadeeq,Wajahat Muhammad,Khan Furqan
Abstract
Staphylococcus aureus is a notorious Gram-positive, non-spore-forming, opportunistic bacterium that causes a variety of infections including bacteremia, endocarditis, pneumonia, skin and soft tissue infections, and several others. Also, the overuse and misuse of drugs attributed to the crises of multidrug resistance especially in MRSA. Objective: Therefore, the aim of this study was to determine the prevalence rate of MRSA, antimicrobial susceptibility profiles of S. aureus, MRSA, and MSSA isolates to a variety of commonly used antibiotics, and its multidrug resistant patterns. Methods: Samples were collected from the microbiology department of HMC Peshawar, Pakistan. Antibiotic susceptibility patterns were determined under CLSI and EUCAST guideline, 2021 by following the Kirby-Bauer disc diffusion method. Results: Out of 106 S. aureus clinical isolates, 83 (78.3%) isolates were identified as MRSA and 23 (21.7%) were MSSA. In MRSA high resistance was exhibited to Penicillin G and cefoxitin (100%), followed by erythromycin 84.34% and ciprofloxacin 79.52%. Meanwhile low resistance was observed to doxycycline 19.28% followed by chloramphenicol 14.46%, teicoplanin and linezolid 2.41% for each respectively. High sensitivity in MRSA isolates was exhibited to linezolid 97.59% followed by teicoplanin 95.18%, chloramphenicol 85.54%, doxycycline 80.72% and fusidic acid 74.70%. A total of n=94 (88.67%) isolates were characterized as MDR. Conclusions: In conclusion, the most effective antibiotics used to treat S. aureus infections were linezolid, teicoplanin, chloramphenicol, doxycycline, fusidic acid, and gentamycin. In addition, the current study also noticed a significant prevalence of resistance to several antibiotics, emphasizing the importance of antibiotic usage monitoring.
Publisher
CrossLinks International Publishers
Reference31 articles.
1. 1. Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nature Reviews Microbiology. 2019 Apr; 17(4):203-218. doi: 10.1038/s41579-018-0147-4.
2. 2. Harkins CP, Pichon B, Doumith M, Parkhill J, Westh H, Tomasz A, et al. Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biology. 2017 Jul; 18(1):130. doi: 10.1186/s13059-017-1252-9.
3. 3. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and therapeutics. 2015 Apr; 40(4):277.
4. 4. Centers for Disease Control and Prevention. Office of Infectious Disease Antibiotic Resistance Threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta. 2013.
5. 5. Wielders CL, Fluit AC, Brisse S, Verhoef J, Schmitz FJ. mecA gene is widely disseminated in Staphylococcus aureus population. Journal of Clinical Microbiology. 2002 Nov; 40(11):3970-5. doi: 10.1128/JCM.40.11.3970-3975.2002.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献